India's ekincare raises strategic investment from MSD IDEA Studio Asia Pacific

ekincare, India’s leading artificial intelligence (AI)-powered integrated digital health gateway, has announced th...

April 29, 2025 | Tuesday | News
Taipei Medical University and MSD launch collaboration to enhance healthcare innovation

Taipei Medical University (TMU) and Merck Sharp & Dohme (MSD) Taiwan have signed a Memorandum of Understanding to co...

April 21, 2025 | Monday | News
MSD launches IDEA Studios to fuel healthcare innovation

MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) has announced the launch of its IDEA Studios, a new initiati...

June 19, 2024 | Wednesday | News
Bio Farma and MSD launch human papillomavirus vaccine in Indonesia

Bio Farma Induk Holding BUMN Pharmacy, with its subsidiaries Kimia Farma and Indofarma, in collaboration with Merck Shar...

August 4, 2023 | Friday | News
MSD signs pact with Indonesia's Bio Farma for HPV vaccine production

Bio Farma, Holding SOE Pharmacy – with its subsidiaries Kimia Farma and Indofarma, has signed a framework agreemen...

December 20, 2022 | Tuesday | News
Hilleman, MSD to develop thermostable next-gen Zaire ebolavirus vaccine

Singapore-based Hilleman Laboratories has announced collaberative efforts to develop a thermostable second-generati...

November 1, 2022 | Tuesday | News
MSD to inject $500M over five years into new manufacturing facility in Singapore

Singapore will soon host a new MSD (Merck & Co., in the U.S. and Canada) secondary packaging facility to support the...

October 5, 2022 | Wednesday | News
Tessa Therapeutics collaborates with MSD to treat Cervical Cancer

Tessa Therapeutics, a clinical-stage immunotherapy company focused on autologous and off-the-shelf, allogeneic therapies...

April 16, 2019 | Tuesday | News
Ascletis brings Former MSD Global VP on board

Ascletis Pharma Inc., an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical need...

March 1, 2019 | Friday | News
FDA approves Sanofi & MSD’s VAXELIS™

The U.S. Food and Drug Administration has approved VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussi...

January 3, 2019 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls